Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease. - Wikidata - awgldk - TriplyDB

Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

http://www.wikidata.org/entity/Q34559800

about

The psychometric properties of the St George's Respiratory Questionnaire (SGRQ) in patients with idiopathic pulmonary fibrosis: a literature review A review of the most common patient-reported outcomes in COPD--revisiting current knowledge and estimating future challenges Connective tissue disease related interstitial lung diseases and idiopathic pulmonary fibrosis: provisional core sets of domains and instruments for use in clinical trials An official American Thoracic Society statement: update on the mechanisms, assessment, and management of dyspnea.Health related quality of life in patients with idiopathic pulmonary fibrosis in clinical practice: insights-IPF registry Test-retest reliability of multidimensional dyspnea profile recall ratings in the emergency department: a prospective, longitudinal study.Cross-Atlantic modification and validation of the A Tool to Assess Quality of Life in Idiopathic Pulmonary Fibrosis (ATAQ-IPF-cA)Appropriateness and acceptability of a Tele-Yoga intervention for people with heart failure and chronic obstructive pulmonary disease: qualitative findings from a controlled pilot study Assessment of dyspnea in asthma: validation of The Dyspnea-12.Reliability and validity of an arabic version of the dyspnea-12 questionnaire for Saudi nationals with chronic obstructive pulmonary disease.Reliability and validity of the multidimensional dyspnea profile Management of the respiratory distress symptom cluster in lung cancer: a randomised controlled feasibility trial.Outcome Measures for Clinical Trials in Interstitial Lung Diseases.Protocol of the PLeural Effusion And Symptom Evaluation (PLEASE) study on the pathophysiology of breathlessness in patients with symptomatic pleural effusions.Nonpharmacological interventions for managing respiratory symptoms in lung cancer.Beyond FEV₁ in COPD: a review of patient-reported outcomes and their measurement.Multidimensional Dyspnea Profile: an instrument for clinical and laboratory research.Patient reported outcome measures in chronic obstructive pulmonary disease: Which to use?Clinical Trial Design Issues in Systemic Sclerosis: an Update.Pathophysiology of dyspnea in COPD.COPD Assessment Test for measurement of health status in patients with idiopathic pulmonary fibrosis: A cross-sectional study.The assessment of breathlessness in pulmonary arterial hypertension: reliability and validity of the Dyspnoea-12.Getting serious about test-retest reliability: a critique of retest research and some recommendations.Dyspnoea and comorbidity contribute to anxiety and depression in interstitial lung disease.Dyspnoea-12: a translation and linguistic validation study in a Swedish setting.Psycho-Physiological Associates of Dyspnea in Hospitalized Patients with Interstitial Lung Diseases: A Cross-Sectional Study.Measuring dyspnoea: new multidimensional instruments to match our 21st century understanding.Assessment and management of refractory breathlessness in interstitial lung disease.A simple dyspnoea scale as part of the assessment to predict outcome across chronic interstitial lung disease.A critique of Rasch analysis using the Dyspnoea-12 as an illustrative example.Validation of the French version of the London Chest Activity of Daily Living scale and the Dyspnea-12 questionnaire.Comparison of patient-reported outcomes during acute exacerbations of chronic obstructive pulmonary disease

P2860

Q26992007-E364F3D8-81E9-4E82-97CF-52B1EC529608 Q26992071-3A48D962-537F-4ACC-A7D6-848EED0AFA10 Q27024062-4CC09B6E-0556-4754-A774-6C32B2CB57DE Q33738878-2A9C6FC4-1D1D-4034-A5AB-3C3AFF347B73 Q33908569-08D1657A-0672-40B0-907A-454A9D77E75D Q34280516-45FE7B49-706B-4361-9484-F75D32597CEC Q34419914-248278A7-044B-4342-9D90-AD8474CB122D Q35074049-ABE31928-7817-49F9-BA5B-F76E0A3C7A93 Q35146573-D2C59A8F-DC3F-488C-9721-4355C79AE7C6 Q35222196-FC03ED79-FFE1-472C-9708-1F307D397D67 Q36009070-38DF8EB2-88CE-4BFE-9782-A9D9DE8BCA9B Q36095774-0E88F884-EA45-4B0A-8DE1-459A50C81624 Q36726418-E4E8A8FB-EECF-4ADF-A566-D114440FF115 Q37177617-C9292D5E-6682-41E2-8FCF-FC5D87957E10 Q37997540-AECA7DEF-D732-404E-900E-0346971874E4 Q38055149-2E7B618B-550C-4FE6-8E60-B891C67EE5ED Q38384866-17E0A39D-53BC-4A45-B55C-A1444FB181D1 Q38711045-EFB28195-BFD8-4C6E-A212-610B55E539E5 Q38825869-EEBA9798-243C-4263-9D71-9777631AC11E Q39170919-35F4F69E-EEEF-4B61-A24F-37DED577C0EA Q39177038-42BB15AB-1E82-40BD-9D75-AD5FFD734CBA Q44044844-A4D6FB5F-AE89-45E2-B087-9A78996C8364 Q44386158-B5ADAD7D-E575-4980-8E5B-7CFFDF9377EA Q44879072-7EF408AB-5642-4A62-A71B-532D47FB4770 Q47094773-56CA2CCC-8FD3-4792-A834-EDCA38A36166 Q47104446-01E56EF6-1C28-4F89-89B1-7F580472F7F1 Q47758414-9E921C78-A2A6-4735-908E-1F638062D4E0 Q47786000-31FD0058-C3AD-4207-AF2E-67731CFDD1FC Q51060153-2060F34A-32CD-4B03-9675-F5D2C5508FDC Q53085179-46C502A8-8D7E-43CC-802F-9A5578CFCFDD Q55520442-5B7C36EB-6407-4F97-8186-66B5B943EE00 Q58577807-3F5FE082-99B1-469D-97EA-B717B5439FEA

P2860

Dyspnea-12 is a valid and reliable measure of breathlessness in patients with interstitial lung disease.

http://www.wikidata.org/entity/Q34559800

description

2010 nî lūn-bûn

@nan

2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@ast

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@en

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@nl

type

label

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@ast

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@en

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@nl

prefLabel

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@ast

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@en

Dyspnea-12 is a valid and reli ...... ith interstitial lung disease.

@nl

P1433

Q34559800-C79381BE-8239-4C03-8F6D-5937DE3BE8A9

P1476

Q34559800-CE2E3F4D-DCEB-491E-BB45-805B1B517F60

P2093

Q34559800-760F9042-E996-4B0A-82AC-3D03294C884A

Q34559800-BB291B7B-278D-4EDA-B5AC-E5A9B826584C

Q34559800-CF8502A4-ECF9-4C8D-9A1E-13B36449C468

Q34559800-F0DFFE06-C248-41F1-AB18-AEC316A9E840

Q34559800-F28062CC-1F9B-4A69-8471-79845C735139

P2860

Q34559800-1CA38E1D-6B0D-46A6-BA6D-DB7E8366FD8C

Q34559800-1EDEC17F-DDCB-4C0C-B837-23A229EAA4AE

Q34559800-2B611256-9E27-45AF-981F-4C6E474CC56D

Q34559800-319D039D-FD9F-4A5A-9F5C-C57C70ABAD3C

Q34559800-3667896D-A30D-4B44-A85E-289E87B1F6F1

Q34559800-43E369B8-4527-4748-80CF-2D5E6A1602CD

Q34559800-5734B6EC-8E2A-4B45-88F8-AEE2085F8B49

Q34559800-588C5463-F028-4FAA-8954-518F05664111

Q34559800-589708F7-A1DD-4C71-92D9-E2944284E3A1

Q34559800-D883A483-D090-41E5-8C62-FA6CD7799428

P304

Q34559800-318C5285-56FF-4DE9-8AB0-A213B384082D

P31

Q34559800-F73AC27E-DFAE-4715-A0E3-5F4AFA74ABBB

P356

Q34559800-B9A52E18-48C7-4B41-B65F-46F4377F59B4

P407

Q34559800-548253F8-772D-4673-9C7C-FA490BF7974B

P433

Q34559800-5553D4AF-0FF1-4ACA-9691-103CB9211E1E

P478

Q34559800-5D8CD8EE-E60B-410C-9567-BF2AB8F114D7

P50

Q34559800-0CCB97E6-4940-40CF-8841-2FCC821317E5

Q34559800-2B0E0437-63E0-4270-81AA-023F9AE3D4C1

P577

Q34559800-624E904E-B90B-4EDE-AA32-1E9E18F6BED4

P5875

Q34559800-0595357D-DD72-4BAE-83EF-E13221BAD9CB

P698

Q34559800-988A202C-3782-4C2C-99E3-6A4FD8038478

P932

Q34559800-7EE3CFBC-1AE5-4B78-9445-905A5C299D15

P356

P1433

P1476

Dyspnea-12 is a valid and reli ...... with interstitial lung disease

@en

P2093

Georges Ng Man Kwong

http://www.w3.org/2001/XMLSchema#string

Jeffrey Swigris

http://www.w3.org/2001/XMLSchema#string

Mark Longshaw

http://www.w3.org/2001/XMLSchema#string

Paul W Jones

http://www.w3.org/2001/XMLSchema#string

Shakeeb H Moosavi

http://www.w3.org/2001/XMLSchema#string

P2860

The hospital anxiety and depression scale

Normative data for the HADS from a large non-clinical sample.

ATS statement: guidelines for the six-minute walk test.

Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society.

Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease.

Health-related quality of life among patients with idiopathic pulmonary fibrosis.

Quantification of dyspnoea using descriptors: development and initial testing of the Dyspnoea-12.

Evaluation of health-related quality-of-life and dyspnea scales in patients with idiopathic pulmonary fibrosis. Correlation with pulmonary function tests.

Health-related quality of life in patients with idiopathic pulmonary fibrosis. What is the main contributing factor?

Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with idiopathic pulmonary fibrosis.

P304

159-164

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1378/CHEST.10-0693

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

139

http://www.w3.org/2001/XMLSchema#string

P50

Anne-Marie Russell

P577

2010-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44901949

http://www.w3.org/2001/XMLSchema#string

P698

20595454

http://www.w3.org/2001/XMLSchema#string

P932

3035488

http://www.w3.org/2001/XMLSchema#string